Beijing, China

Yafang Wang

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 9.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2009-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Yafang Wang: Innovator in Pharmaceutical Chemistry

Introduction

Yafang Wang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating neurological disorders. With a total of 2 patents, his work has the potential to impact the lives of many individuals suffering from various health conditions.

Latest Patents

Wang's latest patents include innovative N-substituted adenosine and adenine derivatives. These compounds are designed for use in pharmaceutical compositions that target insomnia, convulsions, epilepsy, and Parkinson's disease. Additionally, he has developed methods for manufacturing these compounds, which are also applicable in creating health-care products. Another notable patent involves the use of succinate derivative esters for treating dementia, particularly Alzheimer's disease and vascular dementia. His research demonstrates that these esters can enhance learning and memory abilities in dementia models, showcasing their high activity and low toxicity.

Career Highlights

Throughout his career, Yafang Wang has been associated with esteemed institutions such as the Chinese Academy of Medical Sciences and the Chinese Academy of Sciences. His work has garnered attention for its innovative approach to addressing complex health issues through chemical compounds.

Collaborations

Wang has collaborated with notable colleagues, including Jianjun Zhang and Jiangong Shi, contributing to the advancement of research in his field.

Conclusion

Yafang Wang's contributions to pharmaceutical chemistry highlight his dedication to improving health outcomes through innovative inventions. His patents reflect a commitment to addressing significant medical challenges, particularly in the realm of neurological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…